Logo image of ATIP

ATI PHYSICAL THERAPY INC (ATIP) Stock Fundamental Analysis

NYSE:ATIP - New York Stock Exchange, Inc. - US00216W2089 - Common Stock - Currency: USD

1.79  +0.11 (+6.55%)

After market: 1.78 -0.01 (-0.56%)

Fundamental Rating

1

ATIP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ATIP have multiple concerns. ATIP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ATIP had negative earnings in the past year.
In the past year ATIP has reported a negative cash flow from operations.
ATIP Yearly Net Income VS EBIT VS OCF VS FCFATIP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.23%, ATIP is doing worse than 66.97% of the companies in the same industry.
With a Return On Equity value of -109.28%, ATIP is not doing good in the industry: 78.90% of the companies in the same industry are doing better.
ATIP has a Return On Invested Capital of 0.61%. This is comparable to the rest of the industry: ATIP outperforms 40.37% of its industry peers.
Industry RankSector Rank
ROA -8.23%
ROE -109.28%
ROIC 0.61%
ROA(3y)-36.2%
ROA(5y)N/A
ROE(3y)-177.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATIP Yearly ROA, ROE, ROICATIP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -50 -100 -150 -200 -250

1.3 Margins

ATIP has a Operating Margin of 0.86%. This is comparable to the rest of the industry: ATIP outperforms 42.20% of its industry peers.
The Gross Margin of ATIP (16.13%) is worse than 67.89% of its industry peers.
Industry RankSector Rank
OM 0.86%
PM (TTM) N/A
GM 16.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATIP Yearly Profit, Operating, Gross MarginsATIP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ATIP is destroying value.
ATIP has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ATIP is higher compared to a year ago.
ATIP Yearly Shares OutstandingATIP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
ATIP Yearly Total Debt VS Total AssetsATIP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

ATIP has an Altman-Z score of -1.30. This is a bad value and indicates that ATIP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ATIP (-1.30) is worse than 82.57% of its industry peers.
ATIP has a Debt/Equity ratio of 7.55. This is a high value indicating a heavy dependency on external financing.
ATIP's Debt to Equity ratio of 7.55 is on the low side compared to the rest of the industry. ATIP is outperformed by 84.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.55
Debt/FCF N/A
Altman-Z -1.3
ROIC/WACC0.08
WACC8.12%
ATIP Yearly LT Debt VS Equity VS FCFATIP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 1.12 indicates that ATIP should not have too much problems paying its short term obligations.
ATIP's Current ratio of 1.12 is on the low side compared to the rest of the industry. ATIP is outperformed by 70.64% of its industry peers.
ATIP has a Quick Ratio of 1.12. This is a normal value and indicates that ATIP is financially healthy and should not expect problems in meeting its short term obligations.
ATIP has a worse Quick ratio (1.12) than 64.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
ATIP Yearly Current Assets VS Current LiabilitesATIP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

ATIP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.86%, which is quite impressive.
The Revenue has grown by 9.35% in the past year. This is quite good.
EPS 1Y (TTM)65.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-156.99%
Revenue 1Y (TTM)9.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.06%

3.2 Future

The Earnings Per Share is expected to grow by 29.99% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.81% on average over the next years.
EPS Next Y59.22%
EPS Next 2Y29.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.11%
Revenue Next 2Y6.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ATIP Yearly Revenue VS EstimatesATIP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 200M 400M 600M
ATIP Yearly EPS VS EstimatesATIP Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATIP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATIP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATIP Price Earnings VS Forward Price EarningsATIP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ATIP is valued a bit cheaper than 62.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.9
ATIP Per share dataATIP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as ATIP's earnings are expected to grow with 29.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.99%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATIP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATI PHYSICAL THERAPY INC

NYSE:ATIP (12/3/2024, 8:27:39 PM)

After market: 1.78 -0.01 (-0.56%)

1.79

+0.11 (+6.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners68.21%
Inst Owner Change0%
Ins Owners66.19%
Ins Owner Change-1.04%
Market Cap7.89M
Analysts45.71
Price Target3.06 (70.95%)
Short Float %0.68%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-94.58%
Min EPS beat(2)-198.57%
Max EPS beat(2)9.42%
EPS beat(4)2
Avg EPS beat(4)-37.24%
Min EPS beat(4)-198.57%
Max EPS beat(4)43.64%
EPS beat(8)3
Avg EPS beat(8)-144.22%
EPS beat(12)6
Avg EPS beat(12)-88.1%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-2.81%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-2.81%
Max Revenue beat(4)0.75%
Revenue beat(8)4
Avg Revenue beat(8)-0.33%
Revenue beat(12)4
Avg Revenue beat(12)-1.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-45.45%
PT rev (3m)-45.45%
EPS NQ rev (1m)-19.47%
EPS NQ rev (3m)4.21%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)-3.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.11
P/tB N/A
EV/EBITDA 12.9
EPS(TTM)-18.57
EYN/A
EPS(NY)-9.63
Fwd EYN/A
FCF(TTM)-8.62
FCFYN/A
OCF(TTM)-5.89
OCFYN/A
SpS168.22
BVpS16.52
TBVpS-104.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.23%
ROE -109.28%
ROCE 0.78%
ROIC 0.61%
ROICexc 0.63%
ROICexgc 1.91%
OM 0.86%
PM (TTM) N/A
GM 16.13%
FCFM N/A
ROA(3y)-36.2%
ROA(5y)N/A
ROE(3y)-177.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 7.55
Debt/FCF N/A
Debt/EBITDA 13.27
Cap/Depr 34.35%
Cap/Sales 1.62%
Interest Coverage 0.11
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z -1.3
F-Score5
WACC8.12%
ROIC/WACC0.08
Cap/Depr(3y)75.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-156.99%
EPS Next Y59.22%
EPS Next 2Y29.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.06%
Revenue Next Year9.11%
Revenue Next 2Y6.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y119.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year234.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.43%
OCF growth 3YN/A
OCF growth 5YN/A